{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:22Z","timestamp":1787008942433,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 170357"],"award-info":[{"award-number":["CA 170357"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015724","name":"Mayo Clinic Center for Cell Signaling in Gastroenterology","doi-asserted-by":"crossref","award":["NIDDK P30DK084567"],"award-info":[{"award-number":["NIDDK P30DK084567"]}],"id":[{"id":"10.13039\/100015724","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn\u2019s and Colitis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,23]]},"DOI":"10.1093\/ibd\/izx096","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T03:44:58Z","timestamp":1520394298000},"page":"1074-1081","source":"Crossref","is-referenced-by-count":50,"title":["Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis"],"prefix":"10.1093","volume":"24","author":[{"given":"Mohamad A","family":"Mouchli","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Gastroenterology and Hepatology, Carilion Clinic, Roanoke, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, UCSD, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Boardman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Bruining","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Lightner","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B","family":"Rosen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K","family":"Heimbach","sequence":"additional","affiliation":[{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Hasan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Poterucha","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly D","family":"Watt","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda V","family":"Kane","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Raffals","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V","family":"Loftus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"key\n\t\t\t\t20181009112341164_CIT0001","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20181009112341164_CIT0002","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20181009112341164_CIT0003","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00054725-199712000-00007","article-title":"Interactions between chronic liver disease and inflammatory bowel disease","volume":"3","author":"Loftus","year":"1997","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20181009112341164_CIT0004","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20181009112341164_CIT0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/00365529709025107","article-title":"Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn\u2019s disease","volume":"32","author":"Rasmussen","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0006","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/00365529209011174","article-title":"Primary sclerosing cholangitis in patients with ulcerative colitis","volume":"27","author":"Rasmussen","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0007","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365528009181516","article-title":"Sclerosing cholangitis in ulcerative colitis","volume":"15","author":"Schrumpf","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"key\n\t\t\t\t20181009112341164_CIT0009","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3748\/wjg.14.3497","article-title":"Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"14","author":"Sokol","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"J\u00f8rgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20181009112341164_CIT0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02234825","article-title":"Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study","volume":"44","author":"Lindberg","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"key\n\t\t\t\t20181009112341164_CIT0012","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.41.4.522","article-title":"Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study","volume":"41","author":"Kornfeld","year":"1997","journal-title":"Gut"},{"key":"key\n\t\t\t\t20181009112341164_CIT0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"key\n\t\t\t\t20181009112341164_CIT0014","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0015","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20181009112341164_CIT0016","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","article-title":"The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20181009112341164_CIT0017","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/lt.21077","article-title":"Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis","volume":"13","author":"Cholongitas","year":"2007","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20181009112341164_CIT0018","first-page":"434","article-title":"The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease","volume":"9","author":"Mosli","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key\n\t\t\t\t20181009112341164_CIT0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20181009112341164_CIT0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"J\u00f8rgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0021","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00042737-200512000-00018","article-title":"The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation","volume":"17","author":"Ho","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0022","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20181009112341164_CIT0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.2012.05141.x","article-title":"The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series","volume":"36","author":"Sandhu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20181009112341164_CIT0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2036.2012.05217.x","article-title":"Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients","volume":"36","author":"Mohabbat","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20181009112341164_CIT0025","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ajg.2010.33","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation","volume":"105","author":"El-Nachef","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0026","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0b013e3280116ccc","article-title":"Infliximab for ulcerative colitis following liver transplantation","volume":"19","author":"Lal","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0027","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3748\/wjg.v20.i13.3525","article-title":"Clinical management of inflammatory bowel disease in the organ recipient","volume":"20","author":"Indriolo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0028","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ecco-jcc\/jjv182","article-title":"Management of ulcerative colitis using vedolizumab after liver transplantation for primary sclerosing cholangitis","volume":"10","author":"Meszaros","year":"2016","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20181009112341164_CIT0029","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/apt.13861","article-title":"Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis","volume":"45","author":"Hartery","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20181009112341164_CIT0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.mayocp.2012.02.021","article-title":"Long-term medical management of the liver transplant recipient: what the primary care physician needs to know","volume":"87","author":"Singh","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20181009112341164_CIT0031","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/106689690301100406","article-title":"Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern","volume":"11","author":"Papadimitriou","year":"2003","journal-title":"Int J Surg Pathol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0032","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.transproceed.2015.09.043","article-title":"Asymptomatic de novo inflammatory bowel disease late after liver transplantation for primary sclerosing cholangitis: a case report","volume":"47","author":"\u00c5berg","year":"2015","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t20181009112341164_CIT0033","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/TP.0000000000001725","article-title":"Risk factors and outcomes of de novo cancers (excluding nonmelanoma skin cancer) after liver transplantation for primary sclerosing cholangitis","volume":"101","author":"Mouchli","year":"2017","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20181009112341164_CIT0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ajg.2009.561","article-title":"Protein-losing enteropathy: case illustrations and clinical review","volume":"105","author":"Umar","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20181009112341164_CIT0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/TP.0000000000000299","article-title":"Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list","volume":"99","author":"Porrett","year":"2015","journal-title":"Transplantation"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/5\/1074\/25984114\/izx096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T16:21:27Z","timestamp":1719850887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/5\/1074\/4924363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,4,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izx096","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,3,7]]}}}